Top 100 Contractors in NAICS 3254: Pharmaceutical and Medicine Manufacturing, FY2021

Parent companies by net contract obligations Oct 1, 2020 – Sep 30, 2021 Code page on GovTribe

The top 10 won 95% of FY2021 NAICS 3254 contract dollars

Ranking facts

Contract obligations
$55,780,216,011 Net of deobligations, by contracts coded NAICS 3254 or a code under it
Contractors
726 Parent companies with an obligation
Largest contractor
Pfizer Inc. $23.1 billion, 40.7% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV

Full ranking

Rank Contractor Net obligations Share Trend
1 $23,135,362,935
Rank history: #1 in FY2022, #2 in FY2023, not on the FY2024 list and #71 in FY2025; up 23 since FY2020.
2 $11,700,888,945
Rank history: #2 in FY2022, #1 in FY2023, #1 in FY2024 and #1 in FY2025; down 1 since FY2020.
3 $7,363,802,587
Rank history: #4 in FY2022, #21 in FY2023 and not on the FY2024–FY2025 lists; down 1 since FY2020.
4 $5,565,148,165
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
5 $1,913,730,016
Rank history: #3 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
6 $1,663,247,245
Rank history: #5 in FY2022, #7 in FY2023, not on the FY2024 list and #30 in FY2025; up 9 since FY2020.
7 $1,313,638,023
Rank history: #8 in FY2022 and not on the FY2023–FY2025 lists; up 234 since FY2020.
8 $515,938,382
Rank history: #14 in FY2022, #4 in FY2023, #2 in FY2024 and #2 in FY2025; down 4 since FY2020.
9 $287,673,486
Rank history: #7 in FY2022, #63 in FY2023, #14 in FY2024 and #20 in FY2025; down 2 since FY2020.
10 $257,359,270
Rank history: #18 in FY2022, #8 in FY2023 and not on the FY2024–FY2025 lists; down 1 since FY2020.
11 $214,573,577
Rank history: #12 in FY2022 and not on the FY2023–FY2025 lists; down 6 since FY2020.
12 $162,082,167
Rank history: not on the FY2022–FY2025 lists; up 99 since FY2020.
13 $95,497,600
Rank history: #15 in FY2022, #12 in FY2023, #7 in FY2024 and #5 in FY2025; unchanged since FY2020.
14 $86,190,090
Rank history: #40 in FY2022, #42 in FY2023, #75 in FY2024 and not on the FY2025 list; down 8 since FY2020.
15 $79,896,354
Rank history: #10 in FY2022, #10 in FY2023 and not on the FY2024–FY2025 lists; up 35 since FY2020.
16 $76,445,797
Rank history: #17 in FY2022, #11 in FY2023, #22 in FY2024 and #15 in FY2025; up 10 since FY2020.
17 $70,002,309
Rank history: #13 in FY2022, #17 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in FY2020.
18 $69,300,000
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
19 $63,612,248
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
20 $61,567,403
Rank history: #24 in FY2022, #28 in FY2023, #19 in FY2024 and #23 in FY2025; down 2 since FY2020.
21 $54,227,528
Rank history: not on the FY2022–FY2025 lists; up 38 since FY2020.
22 $53,538,814
Rank history: #37 in FY2022, #47 in FY2023, #29 in FY2024 and not on the FY2025 list; up 13 since FY2020.
23 $50,027,140
Rank history: #35 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
24 $49,650,000
Rank history: #21 in FY2022, #15 in FY2023, #12 in FY2024 and #7 in FY2025; down 4 since FY2020.
25 $40,121,477
Rank history: #93 in FY2022 and not on the FY2023–FY2025 lists; down 9 since FY2020.
26
Teva Pharmaceutical Industries Ltd. 2 awardees, including Teva Pharmaceuticals Usa, Inc.
$39,889,900
Rank history: #32 in FY2022, #25 in FY2023, #51 in FY2024 and not on the FY2025 list; up 3 since FY2020.
27 $39,829,252
Rank history: #45 in FY2022 and not on the FY2023–FY2025 lists; up 7 since FY2020.
28 $34,953,404
Rank history: not on the FY2022–FY2023 lists, #27 in FY2024 and #37 in FY2025; new, not ranked in FY2020.
29 $28,397,992
Rank history: #22 in FY2022, #22 in FY2023, #26 in FY2024 and #27 in FY2025; up 13 since FY2020.
30 $25,322,914
Rank history: #33 in FY2022, #24 in FY2023, #21 in FY2024 and #17 in FY2025; up 13 since FY2020.
31 $24,522,725
Rank history: #39 in FY2022, #32 in FY2023, #35 in FY2024 and not on the FY2025 list; down 12 since FY2020.
32 $24,424,137
Rank history: #9 in FY2022, #13 in FY2023, #34 in FY2024 and not on the FY2025 list; up 7 since FY2020.
33 $23,855,151
Rank history: #36 in FY2022, #72 in FY2023 and not on the FY2024–FY2025 lists; down 23 since FY2020.
34 $22,980,675
Rank history: #38 in FY2022, #39 in FY2023, #32 in FY2024 and not on the FY2025 list; down 3 since FY2020.
35 $22,501,800
Rank history: not on the FY2022–FY2024 lists and #21 in FY2025; up 16 since FY2020.
36 $21,000,000
Rank history: not on the FY2022–FY2025 lists; up 195 since FY2020.
37 $19,938,662
Rank history: #43 in FY2022, #40 in FY2023 and not on the FY2024–FY2025 lists; down 9 since FY2020.
38 $19,573,316
Rank history: #56 in FY2022, #41 in FY2023, #43 in FY2024 and not on the FY2025 list; up 59 since FY2020.
39 $18,935,188
Rank history: #20 in FY2022, #62 in FY2023, #88 in FY2024 and not on the FY2025 list; down 18 since FY2020.
40 $15,295,475
Rank history: not on the FY2022–FY2025 lists; up 181 since FY2020.
41 $14,652,640
Rank history: #49 in FY2022, #36 in FY2023 and not on the FY2024–FY2025 lists; down 18 since FY2020.
42 $13,743,102
Rank history: #47 in FY2022, #55 in FY2023, #41 in FY2024 and #83 in FY2025; up 24 since FY2020.
43 $13,476,004
Rank history: #63 in FY2022 and not on the FY2023–FY2025 lists; down 3 since FY2020.
44 $13,251,536
Rank history: not on the FY2022–FY2025 lists; down 17 since FY2020.
45 $13,227,522
Rank history: not on the FY2022–FY2025 lists; up 3 since FY2020.
46 $13,048,850
Rank history: #77 in FY2022 and not on the FY2023–FY2025 lists; up 46 since FY2020.
47 $12,528,000
Rank history: #31 in FY2022, #44 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in FY2020.
48 $12,038,046
Rank history: #61 in FY2022, #82 in FY2023, not on the FY2024 list and #87 in FY2025; up 15 since FY2020.
49 $10,528,442
Rank history: #64 in FY2022, #67 in FY2023, #71 in FY2024 and #63 in FY2025; up 19 since FY2020.
50 $10,000,000
Rank history: not on the FY2022–FY2025 lists; down 36 since FY2020.
51 $9,885,816
Rank history: not on the FY2022 list, #29 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in FY2020.
52 $9,248,182
Rank history: #62 in FY2022, #53 in FY2023, #52 in FY2024 and #97 in FY2025; unchanged since FY2020.
53 $8,344,855
Rank history: not on the FY2022 list, #43 in FY2023, #48 in FY2024 and #8 in FY2025; down 28 since FY2020.
54
Mylan Pharmaceuticals Inc. 2 awardees, including Mylan Specialty LP
$8,250,000
Rank history: not on the FY2022–FY2025 lists; up 270 since FY2020.
55 $8,010,031
Rank history: #11 in FY2022, #54 in FY2023, #49 in FY2024 and not on the FY2025 list; up 9 since FY2020.
56 $7,882,656
Rank history: #54 in FY2022, #45 in FY2023, #50 in FY2024 and #52 in FY2025; down 19 since FY2020.
57 $7,541,658
Rank history: #44 in FY2022, not on the FY2023–FY2024 lists and #56 in FY2025; up 66 since FY2020.
58 $7,507,207
Rank history: #58 in FY2022, #35 in FY2023, #28 in FY2024 and not on the FY2025 list; up 29 since FY2020.
59 $6,932,000
Rank history: #55 in FY2022, not on the FY2023 list, #33 in FY2024 and not on the FY2025 list; down 5 since FY2020.
60
Catalent Indiana LLC
$6,640,000
Rank history: not on the FY2022–FY2025 lists; up 49 since FY2020.
61 $6,366,653
Rank history: #97 in FY2022 and not on the FY2023–FY2025 lists; up 10 since FY2020.
62 $6,253,710
Rank history: #84 in FY2022 and not on the FY2023–FY2025 lists; up 20 since FY2020.
63 $5,520,523
Rank history: #99 in FY2022, #89 in FY2023, not on the FY2024 list and #79 in FY2025; down 8 since FY2020.
64 $5,330,074
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
65 $4,928,795
Rank history: #66 in FY2022, #49 in FY2023, #59 in FY2024 and #41 in FY2025; up 135 since FY2020.
66 $4,626,936
Rank history: #60 in FY2022, #56 in FY2023, #68 in FY2024 and #40 in FY2025; up 6 since FY2020.
67 $4,617,788
Rank history: #96 in FY2022, #51 in FY2023, #58 in FY2024 and not on the FY2025 list; up 16 since FY2020.
68 $4,500,000
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
69 $4,163,649
Rank history: #68 in FY2022, #66 in FY2023, #65 in FY2024 and not on the FY2025 list; up 107 since FY2020.
70
Heyl Chemisch-Pharmazeutische Fabrik GMBH & Co. KG Through Heyltex Corporation
$4,078,224
Rank history: not on the FY2022–FY2025 lists; up 8 since FY2020.
71 $4,078,207
Rank history: #59 in FY2022, #52 in FY2023, #62 in FY2024 and not on the FY2025 list; up 81 since FY2020.
72 $3,741,709
Rank history: #69 in FY2022, #71 in FY2023, #96 in FY2024 and #72 in FY2025; up 21 since FY2020.
73 $3,396,137
Rank history: not on the FY2022 list, #94 in FY2023 and not on the FY2024–FY2025 lists; up 37 since FY2020.
74 $3,200,000
Rank history: #65 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
75 $3,193,438
Rank history: #81 in FY2022, #86 in FY2023, #82 in FY2024 and #89 in FY2025; unchanged since FY2020.
76 $3,162,500
Rank history: not on the FY2022 list, #75 in FY2023, not on the FY2024 list and #58 in FY2025; down 18 since FY2020.
77 $3,160,680
Rank history: #52 in FY2022 and not on the FY2023–FY2025 lists; down 66 since FY2020.
78 $3,098,443
Rank history: #83 in FY2022, #73 in FY2023 and not on the FY2024–FY2025 lists; up 59 since FY2020.
79 $3,047,028
Rank history: #94 in FY2022, #58 in FY2023, #55 in FY2024 and #45 in FY2025; up 37 since FY2020.
80 $2,971,153
Rank history: not on the FY2022–FY2024 lists and #51 in FY2025; unchanged since FY2020.
81 $2,932,777
Rank history: not on the FY2022 list, #77 in FY2023, #78 in FY2024 and not on the FY2025 list; up 349 since FY2020.
82 $2,929,397
Rank history: #41 in FY2022, #23 in FY2023, #61 in FY2024 and not on the FY2025 list; down 60 since FY2020.
83 $2,552,549
Rank history: #76 in FY2022, #92 in FY2023 and not on the FY2024–FY2025 lists; up 57 since FY2020.
84 $2,538,272
Rank history: not on the FY2022–FY2025 lists; up 2 since FY2020.
85 $2,405,848
Rank history: not on the FY2022–FY2025 lists; up 79 since FY2020.
86 $2,400,193
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
87 $2,334,244
Rank history: not on the FY2022 list, #99 in FY2023 and not on the FY2024–FY2025 lists; down 57 since FY2020.
88 $2,269,811
Rank history: #78 in FY2022, #76 in FY2023, #74 in FY2024 and not on the FY2025 list; up 63 since FY2020.
89 $2,266,735
Rank history: not on the FY2022–FY2025 lists; up 16 since FY2020.
90 $2,250,055
Rank history: #67 in FY2022, not on the FY2023 list, #54 in FY2024 and not on the FY2025 list; up 46 since FY2020.
91 $2,230,760
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
92 $2,057,054
Rank history: #79 in FY2022, #80 in FY2023, #70 in FY2024 and #65 in FY2025; up 14 since FY2020.
93 $2,015,908
Rank history: #89 in FY2022, #88 in FY2023, #79 in FY2024 and #99 in FY2025; up 33 since FY2020.
94 $2,000,000
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
95
Greer Laboratories Inc.
$1,904,073
Rank history: not on the FY2022–FY2025 lists; up 13 since FY2020.
96
Avista Pharma Solutions Inc.
$1,837,747
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
97 $1,749,853
Rank history: not on the FY2022–FY2023 lists, #83 in FY2024 and not on the FY2025 list; new, not ranked in FY2020.
98 $1,744,186
Rank history: #72 in FY2022, #74 in FY2023 and not on the FY2024–FY2025 lists; up 16 since FY2020.
99 $1,727,716
Rank history: #70 in FY2022, #65 in FY2023, #72 in FY2024 and #64 in FY2025; up 20 since FY2020.
100 $1,682,879
Rank history: not on the FY2022–FY2025 lists; up 53 since FY2020.
Show 75 more

100 of 726 contractors listed here. See the rest on GovTribe.

Rankings for the codes under NAICS 3254

Code Net obligations Largest contractor
32541 Pharmaceutical and Medicine Manufacturing $55,780,216,011 Pfizer Inc.

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $56.8 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Fiscal year 2021 ran Oct 1, 2020 – Sep 30, 2021. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
  • Rank changes compare with FY2020. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2020 takes the color of the rank change beside it.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 NAICS 3254 contractors in FY2021?

1. Pfizer Inc. ($23.1B), 2. Mckesson Corporation ($11.7B), 3. Modernatx Inc. ($7.36B), 4. Regeneron Pharmaceuticals Inc. ($5.57B), 5. ELI Lilly and Company ($1.91B), 6. Abbott Laboratories ($1.66B), 7. Merck & Co. Inc. ($1.31B), 8. Cencora, Inc. ($516M), 9. Glaxosmithkline LLC ($288M), 10. Emergent Biosolutions Inc. ($257M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work